Código QR (código de barras bidimensional)

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding

The aim of this retrospective study was to compare andexanet alfa and 4-factor prothrombin complex (4F-PCC) for reversal of factor Xa (FXa)-inhibitor bleeding. Patients that received andexanet alfa for reversal were included. An equivalent number of patients administered 4F-PCC for FXa-inhibitor ble...

ver descrição completa

Na minha lista:
Principais autores: Victoria M. Stevens PharmD, BCCCP, Toby C. Trujillo PharmD, FCCP, FAHA, BCPS, Tyree H. Kiser PharmD, FCCM, FCCP, BCPS, Robert MacLaren PharmD, MPH, FCCM, FCCP, Paul M. Reynolds PharmD, BCCCP, Scott W. Mueller PharmD, BCCCP, FCCM, FCCP
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publishing 2021-09-01
coleção:Clinical and Applied Thrombosis/Hemostasis
Acesso em linha:https://doi.org/10.1177/10760296211039020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados